EUVIMEDEUVIMED entdecken
Open Access

Developing a Pseudomonas aeruginosa keratitis model in Swiss albino mice for clinical assessment

Lalan Kumar Arya, Anita Kumari, Rakhi Kusumesh, Pankaj Kumar, Bibhuti Prassan Sinha, Manoj Kumar, Namrata Kumari

The Indian Journal of Medical Research · 2025

DOI: 10.25259/ijmr_1569_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Indian Journal of Medical Research, 2025. Verfasst von Lalan Kumar Arya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Keratitis. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives Pseudomonas aeruginosa is a leading cause of bacterial keratitis, known for its rapid progression, severe corneal damage, and resistance to treatment. Existing animal models exist to study disease mechanisms and therapeutic options require specialised conditions or complex procedures. This study aimed to develop a simplified, cost-effective, and reproducible murine model of P. aeruginosa keratitis using Swiss albino mice for translational research applications.

Methods

Four female Swiss albino mice (6–8 wk old) were maintained under standard conditions. Baseline ocular evaluation was done using a handheld slit lamp. The left corneas were abraded with a sterile 26G needle and inoculated topically with 10 μL of P. aeruginosa (1.0 × 10⁶ CFU/mL, ATCC 19660). The right eyes served as uninfected controls. Clinical signs were assessed on days 1, 2, and 3 using a standardised 0–4 scoring scale. Infection was confirmed through culture, biochemical tests, and PCR targeting the exotoxin A gene. Statistical analysis was performed using one-way ANOVA with Tukey’s post hoc test.

Results

All infected eyes developed progressive keratitis marked by lid swelling, corneal haze, and stromal involvement. Control eyes remained unaffected. Clinical scores increased significantly over time ( P < 0.05). Culture and molecular analyses confirmed successful infection. Interpretation & conclusions This simplified Swiss albino mouse model effectively mimics human P. aeruginosa keratitis and enables cost-efficient study of pathogenesis and therapeutic testing. It can facilitate standardised ophthalmic infection research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsKeratitisAnimalsMiceDisease Models, AnimalFemaleCorneaHumansExotoxinsBacterial Toxins

Stichwörter der Autor:innen

CorneaPseudomonas aeruginosaexperimental modelinfectionkeratitisswiss albino mouse

Substanzen

ExotoxinsBacterial Toxins

Autor:innen und Institutionen

  • Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
  • Central Animal House Facility, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
  • Department of Microbiology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.

Zitieren

APA

Arya, L. K., Kumari, A., Kusumesh, R., Kumar, P., Sinha, B. P., Kumar, M., & Kumari, N. (2025). Developing a Pseudomonas aeruginosa keratitis model in Swiss albino mice for clinical assessment. The Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_1569_2025

Vancouver

Arya LK, Kumari A, Kusumesh R, Kumar P, Sinha BP, Kumar M, et al. Developing a Pseudomonas aeruginosa keratitis model in Swiss albino mice for clinical assessment. The Indian Journal of Medical Research. 2025. doi:10.25259/ijmr_1569_2025

BibTeX
@article{Arya2025,
  author = {Arya, Lalan Kumar and Kumari, Anita and Kusumesh, Rakhi and Kumar, Pankaj and Sinha, Bibhuti Prassan and Kumar, Manoj and Kumari, Namrata},
  title = {Developing a Pseudomonas aeruginosa keratitis model in Swiss albino mice for clinical assessment},
  journal = {The Indian Journal of Medical Research},
  year = {2025},
  doi = {10.25259/ijmr_1569_2025}
}
Kostenlos starten →